E-LIB Suche - Ergebnisse für: Schiano de Colella, J.

1

BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFE..:

Gallamini, A. ; Schiano de Colella, J. ; Viotti, J....
Hematological Oncology. 37 (2019) S2 - p. 292-293 , 2019

Link: https://doi.org/10.1002/..

2

JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLA..:

Laurent, C. ; Nicolae, A. ; Laurent, C....
Hematological Oncology. 37 (2019) S2 - p. 201-201 , 2019

Link: https://doi.org/10.1002/..

3

French early nationwide idecabtagene vicleucel chimeric ant..:

Ferment, B. ; Lambert, J. ; Caillot, D....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

4

Isatuximab plus pomalidomide and dexamethasone in patients ..:

Decaux, Olivier ; Fontan, Jean ; Perrot, Aurore...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

5

A phase II study of lenalidomide and rituximab (R2) combina..:

Noel, Robin ; Zemmour, Christophe ; Montes de Oca, Catalina...
Hematology. 28 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

6

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH R..:

Herbaux, C. ; Schiano de Colella, J. M. ; Thieblemont, C....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

Deep-Learning Assessed Muscular Hypodensity Independently P..:

Jullien, Maxime ; Tessoulin, Benoit ; Ghesquières, Hervé...
Cancers. 13 (2021) 18 - p. 4503 , 2021

Link: https://doi.org/10.3390/..

8

RESISTANCE OF B‐CELL LYMPHOMAS TO CAR‐T CELL THERAPY IS ASS..:

Laurent, C. ; Hamon, M. ; Syrykh, C....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULA..:

Al Tabaa, Y. ; Casasnovas, O. ; Baillet, C....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH R..:

Cartron, G. ; Bachy, E. ; Guidez, S....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

11

La lymphocytose T polyclonale, un syndrome parathymique trè..:

Belmecheri, F. ; Benyamine, A. ; Murati, A....
La Revue de Médecine Interne. 38 (2017) - p. A213-A214 , 2017

Link: https://doi.org/10.1016/..

12

Lenalidomide plus donor-lymphocytes infusion after allogene..:

El-Cheikh, Jean ; Crocchiolo, Roberto ; Furst, Sabine...
Experimental Hematology. 40 (2012) 7 - p. 521-527 , 2012

Link: https://doi.org/10.1016/..

13

Occurrence and severity of adverse events after autologous ..:

Calmels, Boris ; Lemarié, Claude ; Esterni, Benjamin...
Transfusion. 47 (2007) 7 - p. 1268-1275 , 2007

Link: https://doi.org/10.1111/..

14

Bortezomib, thalidomide, and dexamethasone with or without ..:

Moreau, Philippe ; Hulin, Cyrille ; Perrot, Aurore...
The Lancet Oncology. , 2024

Link: https://doi.org/10.1016/..

15

Prospective evaluation of lymphoma response to immunomodula..:

Al Tabaa, Yassine ; Casasnovas, Rene Oliver ; Baillet, Clio...
Blood Advances. 7 (2023) 14 - p. 3735-3738 , 2023

Link: https://doi.org/10.1182/..